Marco Salas, Sergio https://orcid.org/0000-0002-4636-0322
Kuemmerle, Louis B. https://orcid.org/0000-0002-9193-1243
Mattsson-Langseth, Christoffer
Tismeyer, Sebastian
Avenel, Christophe https://orcid.org/0000-0002-1835-921X
Hu, Taobo https://orcid.org/0000-0001-5124-7167
Rehman, Habib https://orcid.org/0000-0002-8671-982X
Grillo, Marco https://orcid.org/0000-0003-2155-0645
Czarnewski, Paulo
Helgadottir, Saga
Tiklova, Katarina
Andersson, Axel https://orcid.org/0000-0002-4714-3127
Rafati, Nima
Chatzinikolaou, Maria
Theis, Fabian J. https://orcid.org/0000-0002-2419-1943
Luecken, Malte D. https://orcid.org/0000-0001-7464-7921
Wählby, Carolina https://orcid.org/0000-0002-4139-7003
Ishaque, Naveed https://orcid.org/0000-0002-8426-901X
Nilsson, Mats https://orcid.org/0000-0001-9985-0387
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (FKZ: 031L0265)
Knut och Alice Wallenbergs Stiftelse (KAW 2018.0172)
Cancerfonden (CAN 2018/604)
Vetenskapsrådet (2019-01238)
Chan Zuckerberg Initiative
Article History
Received: 13 February 2023
Accepted: 4 February 2025
First Online: 13 March 2025
Competing interests
: M.N. was an advisor for 10x Genomics when this manuscript was initially submitted, but he is no longer involved in any advisory role for the company. F.J.T. consults for Immunai, Singularity Bio, CytoReason and Omniscope, and has ownership interest in Dermagnostix and Cellarity. M.D.L. contracted for the Chan Zuckerberg Initiative and received speaker fees from Pfizer and Janssen Pharmaceuticals. S.M.S., C.M.L. and M.G. are co-founders of Spatialist, a data-analysis company focused on spatial omics. The remaining authors declare no competing interests.